BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16920102)

  • 1. The globus pallidus pars externa and Parkinson's disease. Ready for prime time?
    Obeso JA; Rodriguez-Oroz MC; Javier Blesa F; Guridi J
    Exp Neurol; 2006 Nov; 202(1):1-7. PubMed ID: 16920102
    [No Abstract]   [Full Text] [Related]  

  • 2. The basal ganglia in Parkinson's disease: current concepts and unexplained observations.
    Obeso JA; Marin C; Rodriguez-Oroz C; Blesa J; Benitez-Temiño B; Mena-Segovia J; Rodríguez M; Olanow CW
    Ann Neurol; 2008 Dec; 64 Suppl 2():S30-46. PubMed ID: 19127584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of pallidal neuronal discharges in Parkinson's disease patients.
    Berić A; Sterio D; Dogali M; Fazzini E; Eidelberg D; Kolodny E
    Adv Neurol; 1996; 69():123-8. PubMed ID: 8615119
    [No Abstract]   [Full Text] [Related]  

  • 4. Functional organization of the basal ganglia: therapeutic implications for Parkinson's disease.
    Obeso JA; Rodríguez-Oroz MC; Benitez-Temino B; Blesa FJ; Guridi J; Marin C; Rodriguez M
    Mov Disord; 2008; 23 Suppl 3():S548-59. PubMed ID: 18781672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pallidotomy for Parkinson's disease.
    Lozano AM; Lang AE
    Adv Neurol; 2001; 86():413-20. PubMed ID: 11554004
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasticity of the nigropallidal pathway in Parkinson's disease.
    Whone AL; Moore RY; Piccini PP; Brooks DJ
    Ann Neurol; 2003 Feb; 53(2):206-13. PubMed ID: 12557287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-frequency stimulation of the subthalamic nucleus increases pallidal neuronal firing rate in a patient with Parkinson's disease.
    Reese R; Steigerwald F; Pötter M; Herzog J; Deuschl G; Volkmann J; Pinsker MO; Mehdorn HM
    Mov Disord; 2008 Oct; 23(13):1945-7. PubMed ID: 18661546
    [No Abstract]   [Full Text] [Related]  

  • 8. [Patterns of neuronal activity in the basal ganglia nucleus in parkinsonian patients with levodopa-induced dyskinesia].
    Li XY; Zhuang P; Li YJ
    Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(23):1607-12. PubMed ID: 19035099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuronal firing rates and patterns in the globus pallidus internus of patients with cervical dystonia differ from those with Parkinson's disease.
    Tang JK; Moro E; Mahant N; Hutchison WD; Lang AE; Lozano AM; Dostrovsky JO
    J Neurophysiol; 2007 Aug; 98(2):720-9. PubMed ID: 17537900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The functional anatomy of noradrenergic neurons in Parkinson's disease.
    Soldani P; Fornai F
    Funct Neurol; 1999; 14(2):97-109. PubMed ID: 10399622
    [No Abstract]   [Full Text] [Related]  

  • 11. Nondopaminergic neurons in Parkinson's disease.
    Hirsch EC; Orieux G; Muriel MP; Francois C; Feger J
    Adv Neurol; 2003; 91():29-37. PubMed ID: 12449099
    [No Abstract]   [Full Text] [Related]  

  • 12. Distinct changes in evoked and resting globus pallidus activity in early and late Parkinson's disease experimental models.
    Zold CL; Larramendy C; Riquelme LA; Murer MG
    Eur J Neurosci; 2007 Sep; 26(5):1267-79. PubMed ID: 17767504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemistry of Parkinson's disease: is a brain serotonergic deficiency a characteristic of idiopathic Parkinson's disease?
    Kish SJ
    Adv Neurol; 2003; 91():39-49. PubMed ID: 12442662
    [No Abstract]   [Full Text] [Related]  

  • 14. The influence of the subthalamic nucleus upon the damage to the dopamine system following lesions of globus pallidus in rats.
    Wright AK; Arbuthnott GW
    Eur J Neurosci; 2007 Aug; 26(3):642-8. PubMed ID: 17634067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional neuroanatomy of the basal ganglia in Parkinson's disease.
    Wichmann T; DeLong MR
    Adv Neurol; 2003; 91():9-18. PubMed ID: 12442660
    [No Abstract]   [Full Text] [Related]  

  • 16. Bereitschaftspotential preceding voluntary saccades is abnormal in patients with Parkinson's disease.
    Shimizu N; Okiyama R
    Adv Neurol; 1993; 60():398-402. PubMed ID: 8420161
    [No Abstract]   [Full Text] [Related]  

  • 17. Microglial activation is not prevented by tacrolimus but dopamine neuron damage is reduced in a rat model of Parkinson's disease progression.
    Wright AK; Miller C; Williams M; Arbuthnott G
    Brain Res; 2008 Jun; 1216():78-86. PubMed ID: 18495090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic targeting of the globus pallidus internus in Parkinson's disease: imaging versus electrophysiological mapping.
    Lehman RM
    Neurosurgery; 2000 Apr; 46(4):1026. PubMed ID: 10764288
    [No Abstract]   [Full Text] [Related]  

  • 19. [An autopsy case of pallidoluysionigral atrophy with clinical pictures of Parkinson's disease].
    Otake T
    No To Shinkei; 2003 Feb; 55(2):186-93. PubMed ID: 12685002
    [No Abstract]   [Full Text] [Related]  

  • 20. Cortico-basal ganglia-cortical circuitry in Parkinson's disease reconsidered.
    Braak H; Del Tredici K
    Exp Neurol; 2008 Jul; 212(1):226-9. PubMed ID: 18501351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.